AARON TODD MILLER
Allopathic & Osteopathic Physicians|Family Medicine JACKSONVILLE, FL NPI 1023084290
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine FL Novo Nordisk AS All categories
General Payments — all program years on this page
$1,276.03
- Category: General Payments
- Program years: PY2018–2023
- Record count: 76
- As of (CMS publication): 2026-01-23
Latest program year (PY2023): $135.70 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2023) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $135.70 | 8 |
By paying entity
Latest program year (PY2023) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $32.82 | 2 |
| Lundbeck LLC | $21.88 | 1 |
| GlaxoSmithKline, LLC. | $19.40 | 1 |
| Merck Sharp & Dohme Corporation | $16.74 | 1 |
| Amgen Inc. | $16.11 | 1 |
| Exact Sciences Corporation | $15.72 | 1 |
| Janssen Pharmaceuticals, Inc | $13.03 | 1 |
By program year
Records — PY2023 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1003255787 | GlaxoSmithKline, LLC. | $19.40 | 01/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1005918303 | Novo Nordisk Inc | $13.65 | 01/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1005918307 | Novo Nordisk Inc | $19.17 | 04/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1020525607 | Amgen Inc. | $16.11 | 02/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1026648911 | Exact Sciences Corporation | $15.72 | 02/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1032291271 | Lundbeck LLC | $21.88 | 01/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1048702813 | Merck Sharp & Dohme LLC | $16.74 | 01/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 987766785 | Janssen Pharmaceuticals, Inc | $13.03 | 01/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.